Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional

Safety and Efficacy of Ipamorelin for Management of Post-Operative Ileus

ClinicalTrials.gov ID: NCT00672074

Public ClinicalTrials.gov record NCT00672074. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 21, 2026, 2:17 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase II, Double-Blind, Placebo-Controlled, Multiple-Dose Study to Evaluate the Safety and Efficacy of Ipamorelin Compared to Placebo for the Management of Post-Operative Ileus in Patients

Study identification

NCT ID
NCT00672074
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Helsinn Therapeutics (U.S.), Inc
Industry
Enrollment
117 participants

Conditions and interventions

Conditions

Interventions

  • Ipamorelin Drug
  • placebo Drug

Drug

Eligibility (public fields only)

Age range
18 Years to 85 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Mar 31, 2008
Primary completion
Nov 30, 2009
Completion
Nov 30, 2009
Last update posted
Apr 13, 2017

2008 – 2009

United States locations

U.S. sites
19
U.S. states
15
U.S. cities
18
Facility City State ZIP Site status
USC/Norris Cancer Center Los Angeles California 90033
Cedars Sinai Medical Center Los Angeles California 90048
Palo Alto Veterans Hospital Palo Alto California 94304
University of Colorado Hospital Aurora Colorado 80045
Denver VA Hospital Denver Colorado 80220
Washington Hospital Center Washington D.C. District of Columbia 20010
Cleveland Clinic of Weston Weston Florida 33331
St. Joseph's Hospital of Atlanta Atlanta Georgia 30342
University of Illinois at Chicago Chicago Illinois 60612
Indiana University Medical Center Indianapolis Indiana 46202
Ochsner Medical Center New Orleans Louisiana 70121
UMass Memorial Healthcare Worcester Massachusetts 01605
William Beaumont Hospital Royal Oak Michigan 48067
Barnes Jewish Hospital St Louis Missouri 38104
Stony Brook University Medical Center Stony Brook New York 11794
The Christ Hospital Cincinnati Ohio 45219
University Hospitals Case Medical Center Cleveland Ohio 44106
The Pennsylvania State University Hershey Pennsylvania 17033
St. Joseph Hospital Tacoma Washington 98405

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00672074, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Apr 13, 2017 · Synced Jul 21, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00672074 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →